Back
alt_stuff
00:20:05 65 Views
Discussion
Patient selection and outcomes in HIPEC for ovarian and peritoneal cancers Onference Premium
Claim Offer
0 Likes
0 Comments
Save
Share
Description

Dr. Upasana Palo highlights HIPEC in advanced ovarian cancer, emphasizingoptimal patient selection, interval cytoreduction, and cisplatin-based therapy, supported by OV HIPEC trial evidence for improved survival outcomes.

Join our WhatsApp Channel to get updates. (NOTE: The channel is initially on mute, simply click on the unmute icon to start receiving notifications).

Comments
post
Monthly subscription plan
Subscribe Now
Help
Online
Hybrid
Premium
My Space